{
  "id": 6767009,
  "title": "Alzheon outlines plans for major fundraising round despite Phase 3 miss for Alzheimer's drug",
  "url": "https://urgent.news/2026/09/11/alzheon-outlines-plans-for-major-fundraising-round-despite-phase-3",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-11T15:01:59.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/alzheon-outlines-plans-for-major-fundraising-round-despite-phase-3-miss-for-alzheimers-drug/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Alzheon, a biotech that has been attempting to treat Alzheimer's with a checkered drug candidate for more than a decade, is plotting a major fundraise. The Framingham, MA-based biotech outlined an up to $500 million ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}